Global Antibody-drug Conjugates Market Growth 2025-2031

March 2025 | 82 pages | ID: G97ADBB51D3EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Antibody-drug Conjugates market size is predicted to grow from US$ 3162 million in 2025 to US$ 4208 million in 2031; it is expected to grow at a CAGR of 4.9% from 2025 to 2031.

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.

The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.

LP Information, Inc. (LPI) ' newest research report, the “Antibody-drug Conjugates Industry Forecast” looks at past sales and reviews total world Antibody-drug Conjugates sales in 2024, providing a comprehensive analysis by region and market sector of projected Antibody-drug Conjugates sales for 2025 through 2031. With Antibody-drug Conjugates sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody-drug Conjugates industry.

This Insight Report provides a comprehensive analysis of the global Antibody-drug Conjugates landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody-drug Conjugates portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibody-drug Conjugates market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody-drug Conjugates and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody-drug Conjugates.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibody-drug Conjugates market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Adcetris
• Kadcyla

Segmentation by Application:

• Breast Cancer
• Lymphoma

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• ImmunoGen
• Seattle Genetics
• Roche
• Takeda

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antibody-drug Conjugates market?

What factors are driving Antibody-drug Conjugates market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antibody-drug Conjugates market opportunities vary by end market size?

How does Antibody-drug Conjugates break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antibody-drug Conjugates Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Antibody-drug Conjugates by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Antibody-drug Conjugates by Country/Region, 2020, 2024 & 2031
2.2 Antibody-drug Conjugates Segment by Type
  2.2.1 Adcetris
  2.2.2 Kadcyla
2.3 Antibody-drug Conjugates Sales by Type
  2.3.1 Global Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
  2.3.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Antibody-drug Conjugates Sale Price by Type (2020-2025)
2.4 Antibody-drug Conjugates Segment by Application
  2.4.1 Breast Cancer
  2.4.2 Lymphoma
2.5 Antibody-drug Conjugates Sales by Application
  2.5.1 Global Antibody-drug Conjugates Sale Market Share by Application (2020-2025)
  2.5.2 Global Antibody-drug Conjugates Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Antibody-drug Conjugates Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Antibody-drug Conjugates Breakdown Data by Company
  3.1.1 Global Antibody-drug Conjugates Annual Sales by Company (2020-2025)
  3.1.2 Global Antibody-drug Conjugates Sales Market Share by Company (2020-2025)
3.2 Global Antibody-drug Conjugates Annual Revenue by Company (2020-2025)
  3.2.1 Global Antibody-drug Conjugates Revenue by Company (2020-2025)
  3.2.2 Global Antibody-drug Conjugates Revenue Market Share by Company (2020-2025)
3.3 Global Antibody-drug Conjugates Sale Price by Company
3.4 Key Manufacturers Antibody-drug Conjugates Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Antibody-drug Conjugates Product Location Distribution
  3.4.2 Players Antibody-drug Conjugates Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ANTIBODY-DRUG CONJUGATES BY GEOGRAPHIC REGION

4.1 World Historic Antibody-drug Conjugates Market Size by Geographic Region (2020-2025)
  4.1.1 Global Antibody-drug Conjugates Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Antibody-drug Conjugates Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antibody-drug Conjugates Market Size by Country/Region (2020-2025)
  4.2.1 Global Antibody-drug Conjugates Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Antibody-drug Conjugates Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antibody-drug Conjugates Sales Growth
4.4 APAC Antibody-drug Conjugates Sales Growth
4.5 Europe Antibody-drug Conjugates Sales Growth
4.6 Middle East & Africa Antibody-drug Conjugates Sales Growth

5 AMERICAS

5.1 Americas Antibody-drug Conjugates Sales by Country
  5.1.1 Americas Antibody-drug Conjugates Sales by Country (2020-2025)
  5.1.2 Americas Antibody-drug Conjugates Revenue by Country (2020-2025)
5.2 Americas Antibody-drug Conjugates Sales by Type (2020-2025)
5.3 Americas Antibody-drug Conjugates Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antibody-drug Conjugates Sales by Region
  6.1.1 APAC Antibody-drug Conjugates Sales by Region (2020-2025)
  6.1.2 APAC Antibody-drug Conjugates Revenue by Region (2020-2025)
6.2 APAC Antibody-drug Conjugates Sales by Type (2020-2025)
6.3 APAC Antibody-drug Conjugates Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Antibody-drug Conjugates by Country
  7.1.1 Europe Antibody-drug Conjugates Sales by Country (2020-2025)
  7.1.2 Europe Antibody-drug Conjugates Revenue by Country (2020-2025)
7.2 Europe Antibody-drug Conjugates Sales by Type (2020-2025)
7.3 Europe Antibody-drug Conjugates Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antibody-drug Conjugates by Country
  8.1.1 Middle East & Africa Antibody-drug Conjugates Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Antibody-drug Conjugates Revenue by Country (2020-2025)
8.2 Middle East & Africa Antibody-drug Conjugates Sales by Type (2020-2025)
8.3 Middle East & Africa Antibody-drug Conjugates Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibody-drug Conjugates
10.3 Manufacturing Process Analysis of Antibody-drug Conjugates
10.4 Industry Chain Structure of Antibody-drug Conjugates

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Antibody-drug Conjugates Distributors
11.3 Antibody-drug Conjugates Customer

12 WORLD FORECAST REVIEW FOR ANTIBODY-DRUG CONJUGATES BY GEOGRAPHIC REGION

12.1 Global Antibody-drug Conjugates Market Size Forecast by Region
  12.1.1 Global Antibody-drug Conjugates Forecast by Region (2026-2031)
  12.1.2 Global Antibody-drug Conjugates Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antibody-drug Conjugates Forecast by Type (2026-2031)
12.7 Global Antibody-drug Conjugates Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 ImmunoGen
  13.1.1 ImmunoGen Company Information
  13.1.2 ImmunoGen Antibody-drug Conjugates Product Portfolios and Specifications
  13.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 ImmunoGen Main Business Overview
  13.1.5 ImmunoGen Latest Developments
13.2 Seattle Genetics
  13.2.1 Seattle Genetics Company Information
  13.2.2 Seattle Genetics Antibody-drug Conjugates Product Portfolios and Specifications
  13.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Seattle Genetics Main Business Overview
  13.2.5 Seattle Genetics Latest Developments
13.3 Roche
  13.3.1 Roche Company Information
  13.3.2 Roche Antibody-drug Conjugates Product Portfolios and Specifications
  13.3.3 Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Roche Main Business Overview
  13.3.5 Roche Latest Developments
13.4 Takeda
  13.4.1 Takeda Company Information
  13.4.2 Takeda Antibody-drug Conjugates Product Portfolios and Specifications
  13.4.3 Takeda Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Takeda Main Business Overview
  13.4.5 Takeda Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Antibody-drug Conjugates Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antibody-drug Conjugates Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Adcetris
Table 4. Major Players of Kadcyla
Table 5. Global Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 6. Global Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Table 7. Global Antibody-drug Conjugates Revenue by Type (2020-2025) & ($ million)
Table 8. Global Antibody-drug Conjugates Revenue Market Share by Type (2020-2025)
Table 9. Global Antibody-drug Conjugates Sale Price by Type (2020-2025) & (USD/Kg)
Table 10. Global Antibody-drug Conjugates Sale by Application (2020-2025) & (Kg)
Table 11. Global Antibody-drug Conjugates Sale Market Share by Application (2020-2025)
Table 12. Global Antibody-drug Conjugates Revenue by Application (2020-2025) & ($ million)
Table 13. Global Antibody-drug Conjugates Revenue Market Share by Application (2020-2025)
Table 14. Global Antibody-drug Conjugates Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Antibody-drug Conjugates Sales by Company (2020-2025) & (Kg)
Table 16. Global Antibody-drug Conjugates Sales Market Share by Company (2020-2025)
Table 17. Global Antibody-drug Conjugates Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Antibody-drug Conjugates Revenue Market Share by Company (2020-2025)
Table 19. Global Antibody-drug Conjugates Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Antibody-drug Conjugates Producing Area Distribution and Sales Area
Table 21. Players Antibody-drug Conjugates Products Offered
Table 22. Antibody-drug Conjugates Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Antibody-drug Conjugates Sales by Geographic Region (2020-2025) & (Kg)
Table 26. Global Antibody-drug Conjugates Sales Market Share Geographic Region (2020-2025)
Table 27. Global Antibody-drug Conjugates Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Antibody-drug Conjugates Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Antibody-drug Conjugates Sales by Country/Region (2020-2025) & (Kg)
Table 30. Global Antibody-drug Conjugates Sales Market Share by Country/Region (2020-2025)
Table 31. Global Antibody-drug Conjugates Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Antibody-drug Conjugates Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Antibody-drug Conjugates Sales by Country (2020-2025) & (Kg)
Table 34. Americas Antibody-drug Conjugates Sales Market Share by Country (2020-2025)
Table 35. Americas Antibody-drug Conjugates Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 37. Americas Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 38. APAC Antibody-drug Conjugates Sales by Region (2020-2025) & (Kg)
Table 39. APAC Antibody-drug Conjugates Sales Market Share by Region (2020-2025)
Table 40. APAC Antibody-drug Conjugates Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 42. APAC Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 43. Europe Antibody-drug Conjugates Sales by Country (2020-2025) & (Kg)
Table 44. Europe Antibody-drug Conjugates Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 46. Europe Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 47. Middle East & Africa Antibody-drug Conjugates Sales by Country (2020-2025) & (Kg)
Table 48. Middle East & Africa Antibody-drug Conjugates Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 50. Middle East & Africa Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities of Antibody-drug Conjugates
Table 52. Key Market Challenges & Risks of Antibody-drug Conjugates
Table 53. Key Industry Trends of Antibody-drug Conjugates
Table 54. Antibody-drug Conjugates Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Antibody-drug Conjugates Distributors List
Table 57. Antibody-drug Conjugates Customer List
Table 58. Global Antibody-drug Conjugates Sales Forecast by Region (2026-2031) & (Kg)
Table 59. Global Antibody-drug Conjugates Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Antibody-drug Conjugates Sales Forecast by Country (2026-2031) & (Kg)
Table 61. Americas Antibody-drug Conjugates Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Antibody-drug Conjugates Sales Forecast by Region (2026-2031) & (Kg)
Table 63. APAC Antibody-drug Conjugates Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Antibody-drug Conjugates Sales Forecast by Country (2026-2031) & (Kg)
Table 65. Europe Antibody-drug Conjugates Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Antibody-drug Conjugates Sales Forecast by Country (2026-2031) & (Kg)
Table 67. Middle East & Africa Antibody-drug Conjugates Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Antibody-drug Conjugates Sales Forecast by Type (2026-2031) & (Kg)
Table 69. Global Antibody-drug Conjugates Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Antibody-drug Conjugates Sales Forecast by Application (2026-2031) & (Kg)
Table 71. Global Antibody-drug Conjugates Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. ImmunoGen Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 73. ImmunoGen Antibody-drug Conjugates Product Portfolios and Specifications
Table 74. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. ImmunoGen Main Business
Table 76. ImmunoGen Latest Developments
Table 77. Seattle Genetics Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 78. Seattle Genetics Antibody-drug Conjugates Product Portfolios and Specifications
Table 79. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Seattle Genetics Main Business
Table 81. Seattle Genetics Latest Developments
Table 82. Roche Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 83. Roche Antibody-drug Conjugates Product Portfolios and Specifications
Table 84. Roche Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. Roche Main Business
Table 86. Roche Latest Developments
Table 87. Takeda Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 88. Takeda Antibody-drug Conjugates Product Portfolios and Specifications
Table 89. Takeda Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Takeda Main Business
Table 91. Takeda Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Antibody-drug Conjugates
Figure 2. Antibody-drug Conjugates Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibody-drug Conjugates Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Antibody-drug Conjugates Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antibody-drug Conjugates Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antibody-drug Conjugates Sales Market Share by Country/Region (2024)
Figure 10. Antibody-drug Conjugates Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Adcetris
Figure 12. Product Picture of Kadcyla
Figure 13. Global Antibody-drug Conjugates Sales Market Share by Type in 2025
Figure 14. Global Antibody-drug Conjugates Revenue Market Share by Type (2020-2025)
Figure 15. Antibody-drug Conjugates Consumed in Breast Cancer
Figure 16. Global Antibody-drug Conjugates Market: Breast Cancer (2020-2025) & (Kg)
Figure 17. Antibody-drug Conjugates Consumed in Lymphoma
Figure 18. Global Antibody-drug Conjugates Market: Lymphoma (2020-2025) & (Kg)
Figure 19. Global Antibody-drug Conjugates Sale Market Share by Application (2024)
Figure 20. Global Antibody-drug Conjugates Revenue Market Share by Application in 2025
Figure 21. Antibody-drug Conjugates Sales by Company in 2025 (Kg)
Figure 22. Global Antibody-drug Conjugates Sales Market Share by Company in 2025
Figure 23. Antibody-drug Conjugates Revenue by Company in 2025 ($ millions)
Figure 24. Global Antibody-drug Conjugates Revenue Market Share by Company in 2025
Figure 25. Global Antibody-drug Conjugates Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Antibody-drug Conjugates Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Antibody-drug Conjugates Sales 2020-2025 (Kg)
Figure 28. Americas Antibody-drug Conjugates Revenue 2020-2025 ($ millions)
Figure 29. APAC Antibody-drug Conjugates Sales 2020-2025 (Kg)
Figure 30. APAC Antibody-drug Conjugates Revenue 2020-2025 ($ millions)
Figure 31. Europe Antibody-drug Conjugates Sales 2020-2025 (Kg)
Figure 32. Europe Antibody-drug Conjugates Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Antibody-drug Conjugates Sales 2020-2025 (Kg)
Figure 34. Middle East & Africa Antibody-drug Conjugates Revenue 2020-2025 ($ millions)
Figure 35. Americas Antibody-drug Conjugates Sales Market Share by Country in 2025
Figure 36. Americas Antibody-drug Conjugates Revenue Market Share by Country (2020-2025)
Figure 37. Americas Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Figure 38. Americas Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Figure 39. United States Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Antibody-drug Conjugates Sales Market Share by Region in 2025
Figure 44. APAC Antibody-drug Conjugates Revenue Market Share by Region (2020-2025)
Figure 45. APAC Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Figure 46. APAC Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Figure 47. China Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 51. India Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Antibody-drug Conjugates Sales Market Share by Country in 2025
Figure 55. Europe Antibody-drug Conjugates Revenue Market Share by Country (2020-2025)
Figure 56. Europe Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Figure 57. Europe Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Figure 58. Germany Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 59. France Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Figure 66. Egypt Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Antibody-drug Conjugates Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Antibody-drug Conjugates in 2025
Figure 72. Manufacturing Process Analysis of Antibody-drug Conjugates
Figure 73. Industry Chain Structure of Antibody-drug Conjugates
Figure 74. Channels of Distribution
Figure 75. Global Antibody-drug Conjugates Sales Market Forecast by Region (2026-2031)
Figure 76. Global Antibody-drug Conjugates Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Antibody-drug Conjugates Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Antibody-drug Conjugates Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Antibody-drug Conjugates Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Antibody-drug Conjugates Revenue Market Share Forecast by Application (2026-2031)